Cytokinetics (CYTK) FCF Margin (2016 - 2024)
Historic FCF Margin for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to 748.15%.
- Cytokinetics' FCF Margin rose 51808100.0% to 748.15% in Q4 2024 from the same period last year, while for Dec 2024 it was 5409.36%, marking a year-over-year increase of 109306000.0%. This contributed to the annual value of 1060.47% for FY2024, which is 65817000.0% up from last year.
- Per Cytokinetics' latest filing, its FCF Margin stood at 748.15% for Q4 2024, which was up 51808100.0% from 22073.65% recorded in Q3 2024.
- In the past 5 years, Cytokinetics' FCF Margin ranged from a high of 748.15% in Q4 2024 and a low of 39949.4% during Q2 2024
- In the last 5 years, Cytokinetics' FCF Margin had a median value of 1920.76% in 2021 and averaged 6998.22%.
- Over the last 5 years, Cytokinetics' FCF Margin had its largest YoY gain of 51808100bps in 2024, and its largest YoY loss of -258258700bps in 2024.
- Over the past 5 years, Cytokinetics' FCF Margin (Quarter) stood at 361.69% in 2020, then soared by 57bps to 155.95% in 2021, then crashed by -3222bps to 5181.14% in 2022, then increased by 14bps to 4432.66% in 2023, then soared by 117bps to 748.15% in 2024.
- Its FCF Margin was 748.15% in Q4 2024, compared to 22073.65% in Q3 2024 and 39949.4% in Q2 2024.